首页> 外文会议>Pattern recognition in bioinformatics >Wrapper- and Ensemble-Based Feature Subset Selection Methods for Biomarker Discovery in Targeted Metabolomics
【24h】

Wrapper- and Ensemble-Based Feature Subset Selection Methods for Biomarker Discovery in Targeted Metabolomics

机译:靶向代谢组学中基于生物标志物的包装和基于集合的特征子集选择方法

获取原文
获取原文并翻译 | 示例

摘要

The discovery of markers allowing for accurate classification of metabolically very similar proband groups constitutes a challenging problem. We apply several search heuristics combined with different classifier types to targeted metabolomics data to identify compound subsets that classify plasma samples of insulin sensitive and -resistant subjects, both suffering from non-alcoholic fatty liver disease. Additionally, we integrate these methods into an ensemble and screen selected subsets for common features. We investigate, which methods appear the most suitable for the task, and test feature subsets for robustness and re-producibility. Furthermore, we consider the predictive potential of different compound classes. We find that classifiers fail in discriminating the non-selected data accurately, but benefit considerably from feature subset selection. Especially, a Pareto-based multi-objective genetic algorithm detects highly discriminative subsets and outperforms widely used heuristics. When transferred to new data, feature sets assembled by the ensemble approach show greater robustness than those selected by single methods.
机译:发现允许对代谢非常相似的先证者群体进行准确分类的标记物构成了挑战性的问题。我们将几种搜索试探法与不同的分类器类型相结合,应用于有针对性的代谢组学数据,以识别可对均患有非酒精性脂肪肝疾病的胰岛素敏感和抗药性受试者的血浆样本进行分类的化合物子集。此外,我们将这些方法集成到一个集合中,并筛选出选定的子集以实现常见功能。我们调查了哪种方法最适合该任务,并测试了功能子集的鲁棒性和可重复性。此外,我们考虑了不同化合物类别的预测潜力。我们发现分类器无法准确地区分未选择的数据,但从特征子集选择中受益匪浅。尤其是,基于帕累托的多目标遗传算法可检测出具有高度区分性的子集,并且性能优于广泛使用的启发式算法。当传输到新数据时,通过集成方法组装的特征集显示出比通过单一方法选择的特征集更高的鲁棒性。

著录项

  • 来源
    《Pattern recognition in bioinformatics》|2011年|p.121-132|共12页
  • 会议地点 Delft(NL);Delft(NL)
  • 作者单位

    Center for Bioinformatics (ZBIT), University of Tubingen, D-72076 Tubingen, Germany;

    Division of Clinical Chemistry and Pathobiochemistry (Central Laboratory),University Hospital Tubingen, D-72076 Tubingen, Germany,Paul-Langerhans-Institute Tubingen, Member of the German Centre for Diabetes Research (DZD), Eberhard Karls University Tubingen, Tubingen, Germany;

    Division of Clinical Chemistry and Pathobiochemistry (Central Laboratory),University Hospital Tubingen, D-72076 Tubingen, Germany,Paul-Langerhans-Institute Tubingen, Member of the German Centre for Diabetes Research (DZD), Eberhard Karls University Tubingen, Tubingen, Germany;

    Division of Clinical Chemistry and Pathobiochemistry (Central Laboratory),University Hospital Tubingen, D-72076 Tubingen, Germany,Paul-Langerhans-Institute Tubingen, Member of the German Centre for Diabetes Research (DZD), Eberhard Karls University Tubingen, Tubingen, Germany;

    Division of Clinical Chemistry and Pathobiochemistry (Central Laboratory),University Hospital Tubingen, D-72076 Tubingen, Germany,Paul-Langerhans-Institute Tubingen, Member of the German Centre for Diabetes Research (DZD), Eberhard Karls University Tubingen, Tubingen, Germany;

    Center for Bioinformatics (ZBIT), University of Tubingen, D-72076 Tubingen, Germany;

  • 会议组织
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物工程学(生物技术);
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号